PAL reports 247% increase first quarter net profit

The Palace Amusement Company (1921) Limited (PAL) for the three months ended September 30, 2017 booked an 12% improvement in revenue to $259.96 million (2016: $231.84 million), while Direct Expenses increased by 9% to $204.66 million (2016: $187.09 million). As a result, Gross Profit increased by 24% to $55.30 million (2016: $44.75 million)

Other Operating Income declined to $2.48 million (2016: $2.54 million), a 2% decline while Administrative Expenses increased by 8% to $47.89 million (2016: $44.26 million). Consequently, Operating Profit for the period grew to $9.89 million relative to the $3.03 million reported for the corresponding period in 2016.

Interest Expense rose to $592,000, a 71% increase compared to $346,000 recorded in 2016. Net Profit for the period was 247% higher than the prior year, totalling $9.30 million (2016: $2.68 million).

Profits attributable to Stockholder’s of the Company amounted to $9.34 million for the period relative to $2.73 million in 2016, a 247% increase year over year.

Total Comprehensive Income for the first quarter amounted to $11.07 million relative to $2.49 million.

As such, the earnings-per-share for the period amounted to $6.50. The twelve month earnings-per-share amounted to $30.72.  The amount of shares used in our calculation is 1,437,028.

 

Balance Sheet Highlights:

 The company, as at September 30, 2017, recorded total assets of $506.17 million, a increase of 13% when compared to $447.66 million recorded last year. the growth year over year was due mainly to a 247% increase in cash and bank balances which closed at $86.02 million (2016: $24.80 million).

Total Stockholders’ Equity as at September 30, 2016 closed at $367.49 million, compared to $317.17 million for the corresponding period last year. This resulted in a book value of $255.73 per share compared to $220.72 as at September 30, 2016.

 

 

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

 

More Stories from the Market
shutterstock_609342323
March 25, 2026   Sagicor Group Jamaica Limited (SJ) has declared a dividend of $0.89 per stock unit payable on May 6, 2026, to stockholders…
shutterstock_148562033
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that a senior officer purchased 276,992 PJAM shares on March 24, 2026. &…
shutterstock_453968572
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that on March 24, 2026, three Directors were issued a total of 50,634 PJAM sh…
shutterstock_148562033
March 25, 2026   Supreme Ventures Limited (SVL) has advised that on March 17, 2026, a Director purchased 319,424 SVL shares and a related e…
shutterstock_148562033
March 25, 2026   IronRock Insurance Company Limited (ROC) has advised that connected parties sold a total of 70,939 ROC shares during the p…
shutterstock_453968572
March 25, 2026 United States: US Import Prices Jumped by the Most Since 2022 Ahead of War   The cost of imports into the US jumped in Febr…
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…